Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Laura Forgione
Observed names:
L Forgione,
L. Forgione
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institutions:
CEINGE Biotecnologie Avanzate Franco Salvatore (Italy),
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
University of Southampton,
University of Naples Federico II
ORCID:
0000-0001-5271-9947
Observed ORCID:
0000-0001-5271-9947
OpenAlex ID:
A5004893670
RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial
2017
·
N. Normanno
, R. Esposito Abate
, et al.
·
Annals of Oncology
·
119
EGFR mutations in lung cancer: from tissue testing to liquid biopsy
2015
·
Francesca Fenizia
, Antonella De Luca
, et al.
·
Future Oncology
·
99
The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodies
2013
·
Claudia Esposito
, Anna Maria Rachiglio
, et al.
·
Cancer Biology & Therapy
·
66
Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer
2017
·
Marianna Gallo
, Antonella De Luca
, et al.
·
Translational Lung Cancer Research
·
62
PDF
A child cohort study from southern Italy enlarges the genetic spectrum of hypertrophic cardiomyopathy
2009
·
G Frisso
, G Limongelli
, et al.
·
Clinical Genetics
·
47
Circulating Tumor DNA Testing Opens New Perspectives in Melanoma Management
2020
·
Alessandra Sacco
, Laura Forgione
, et al.
·
Cancers
·
43
PDF
Genomic alterations in cholangiocarcinoma: clinical significance and relevance to therapy
2022
·
Marianeve Carotenuto
, Alessandra Sacco
, et al.
·
Exploration of Targeted Anti-tumor Therapy
·
39
PDF
The role of circulating free DNA in the management of NSCLC
2018
·
Riziero Esposito Abate
, Raffaella Pasquale
, et al.
·
Expert Review of Anticancer Therapy
·
29
Assessment of High-Sensitive Methods for the Detection of EGFR Mutations in Circulating Free Tumor DNA from NSCLC Patients
2015
·
Raffaella Pasquale
, Francesca Fenizia
, et al.
·
Pharmacogenomics
·
29
Targeted sequencing analysis of cell-free DNA from metastatic non-small-cell lung cancer patients: clinical and biological implications
2020
·
Raffaella Pasquale
, Laura Forgione
, et al.
·
Translational Lung Cancer Research
·
17
PDF
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies
2022
·
Anna Maria Rachiglio
, Laura Forgione
, et al.
·
Cancers
·
11
PDF
Colorectal cancer genomic biomarkers in the clinical management of patients with metastatic colorectal carcinoma
2020
·
Anna Maria Rachiglio
, Alessandra Sacco
, et al.
·
Exploration of Targeted Anti-tumor Therapy
·
10
PDF
Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical Diagnostics
2022
·
Cristin Roma
, Alessandra Sacco
, et al.
·
Diagnostics
·
9
PDF
Analysis of liquid biopsies from metastatic colorectal carcinoma (mCRC) patients (pts) enrolled in the ERMES clinical trial.
2018
·
Nicola Normanno
, Carlo Barone
, et al.
·
Journal of Clinical Oncology
·
2
Analysis of liquid biopsies from metastatic colorectal carcinoma (mCRC) patients (pts) enrolled in the CAPRI GOIM clinical trial
2017
·
N. Normanno
, R. Esposito Abate
, et al.
·
Annals of Oncology
·
1
PDF
57P Targeted sequencing of plasma-derived cfDNA in patients with metastatic NSCLC
2018
·
R. Pasquale
, F. Bergantino
, et al.
·
Journal of Thoracic Oncology
Show more works
View as search
Works count:
16
Citation count:
583
H-index:
11
I10-index:
12
Year
Topic
Type